Profile data is unavailable for this security.
About the company
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
- Revenue in INR (TTM)2.76bn
- Net income in INR94.42m
- Incorporated1942
- Employees48.00
- LocationBalaxi Pharmaceuticals LtdPlot No: 409, 3rd Floor,Maps TowersJubilee Hills,Road No:81, HyderabadHYDERABAD 500096IndiaIND
- Phone+91 4 023555300
- Fax+91 4 023558085
- Websitehttps://balaxipharma.in/
| Holder | Shares | % Held |
|---|---|---|
| Elara Capital Plc (Investment Management)as of 30 Sep 2024 | 4.58m | 8.29% |
